CCI approves acquisition of minority stake of BDR Pharmaceuticals International Private Limited by Multiples Private Equity Fund III, SRF Transnational Holdings Limited, Balkrishna Industries Limited, Dharmayug Investments Limited, QRG Investments and Holdings Limited, Mr. Nishant K. Agarwal and Ms. Mallika Srinivasan https://www.taxtmi.com/news?id=25333 CCI approved the acquisition of a minority equity stake in BDR Pharmaceuticals by Multiples Private Equity Fund III and several financial investors, a notified combination under Section 5(a) of the Competition Act, 2002. The parties comprise an Alternative Investment Fund, NBFCs, corporate and individual investors. BDR operates in oncology, critical care, gynecology and neurology and provides manufacture and sale of APIs, formulations, and contract development and manufacturing services. A detailed CCI order will follow. en-us Mon, 18 Apr 2022 18:34:59 +0530 Mon, 18 Apr 2022 18:34:59 +0530 TaxTMI RSS Generator CCI approves acquisition of minority stake of BDR Pharmaceuticals International Private Limited by Multiples Private Equity Fund III, SRF Transnational Holdings Limited, Balkrishna Industries Limited, Dharmayug Investments Limited, QRG Investments and Holdings Limited, Mr. Nishant K. Agarwal and Ms. Mallika Srinivasan https://www.taxtmi.com/news?id=25333 CCI approved the acquisition of a minority equity stake in BDR Pharmaceuticals by Multiples Private Equity Fund III and several financial investors, a notified combination under Section 5(a) of the Competition Act, 2002. The parties comprise an Alternative Investment Fund, NBFCs, corporate and individual investors. BDR operates in oncology, critical care, gynecology and neurology and provides manufacture and sale of APIs, formulations, and contract development and manufacturing services. A detailed CCI order will follow. News - Mon, 18 Apr 2022 18:34:59 +0530 https://www.taxtmi.com/news?id=25333